AVROBIO Inc (AVRO)
$0.00 $0.00 (0.00%) 4:38 PM 12/13/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$5.24M -
Day's Range
- - - -
Volume
212,723 -
52 Week Low / High
- - - -
PE Ratio
0.17x -
PEG Ratio
- -
Dividend Frequency
-
AVRO's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 1
- Strong Buy
- 0
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $3.67
- Target Price
Company News
-
AVROBIO and Tectonic Therapeutic Announce Merger — Jan 30th, 2024
Combined company to be Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing Tectonic’s novel GPCR-targeted therapeutic proteins $130.7 million in private financing commitments with new and existing leading life sciences investors in connection with merger Combin...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$